Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol and postoperative nausea and vomiting after gastrointestinal endoscopy under general anesthesia
ChiCTR2500111433Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tramadol in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Incidence of postoperative nausea and vomiting and Sedative and analgesic effects. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
tramadol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2500111433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111433.